Related Experiment Videos
Metastatic medulloblastoma--therapeutic success through molecular target identification?
The Pharmacogenomics Journal
|May 7, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.
AJNR. American journal of neuroradiology·2022
Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry Study.
Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2017
Amplicon-based long-read sequencing for accurate CYP2D6 gene deletion and duplication detection using CYP2D7 as a reference gene.
The pharmacogenomics journal·2026
Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects.
The pharmacogenomics journal·2026
Effects of CYP3A4, CYP3A5, and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation.
The pharmacogenomics journal·2026
Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study.
The pharmacogenomics journal·2026
Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.
The pharmacogenomics journal·2026
Deficiency of GLUT1 in macrophages reprograms tumor-associated macrophages to normalize tumor vasculature and retards the progression of tumors.
International journal of biological sciences·2026
From static risk to dynamic disease monitoring: the role of MRD and immune profiling in multiple myeloma.
Frontiers in immunology·2026
Doravirine and islatravir for HIV-1 treatment: A systematic review and meta-analysis with GRADE assessment.
Therapeutic advances in infectious disease·2026
Advancement in Inflammation-responsive Drug Delivery System for Chronic Inflammation.
Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026